Arbuckle Stuart A sold VRTX
February 21, 2024 · Form 4 insider transaction
Arbuckle Stuart A sold 3,603 shares of Vertex Pharmaceuticals Incorporated at $421.77 per share, a transaction worth $1.52M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,603
Price
$421.77
Total value
$1.52M
InsiderArbuckle Stuart A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 21, 2024
Filing dateFebruary 23, 2024
Shares owned after59,439
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.